Annual report pursuant to Section 13 and 15(d)

Supplemental Disclosure of Cash Flow Information (Tables)

v3.19.3
Supplemental Disclosure of Cash Flow Information (Tables)
12 Months Ended
Dec. 31, 2018
Supplemental Cash Flow Elements [Abstract]  
Schedule of Supplemental Cash Flow Information
  Year Ended December 31,  
    2018     2017  
Cash paid for interest   $ 313,918     $ 1,200,759  
Cash paid for income taxes   $ 23,362     $ 541,313  
                 
Acquisition of Jamestown Regional Medical Center:                
Inventory   $ 450,682     $ -  
Prepaid and other assets     310,385       -  
Property and equipment     7,129,484       -  
Intangible assets     504,806       -  
Accrued expenses     (193,966 )     -  
                 
Non-cash investing and financing activities:                
Cashless exercise of warrants     4,619,150       -  
Exchange of debentures for Series I-2 Preferred Stock     3,127,556       -  
Note payable and accrued expenses settled through issuance of Series J Preferred Stock     250,000       -  
Common stock issued for conversion of Series I-2 Preferred Stock     1,513,105       -  
Beneficial conversion feature    

192,308

         
Services and severance settled through the issuances of common stock     -       161,003  
Exchange of convertible debentures for convertible debentures and warrants     -       10,734,336  
Series F Preferred Stock issued for business acquisition     -       174,097  
Notes payable and warrants settled through issuance of common stock     -       440,000  
Convertible debentures issued in exchange for Series H Preferred Stock     -       2,695,760  
Debentures converted into common stock     8,128,044       7,306,314  
Deemed dividend for trigger of down round provision feature     231,843,826       53,341,619  
Conversions of preferred stock into common stock     -       7,785,000  
Value of convertible liabilities     -       12,435,250